The cyclin kinase inhibitor p21(CIP1/WAF1) limits glomerular epithelial cell proliferation in experimental glomerulonephritis

Kidney International

Volumn 55, Issue 6, 1999, Pages 2349-2361

  Yoon Goo, Kim ^a,b   Alpers, Charles E ^a,b   Brugarolas, James ^a,b   Johnson, Richard J ^a,b   Couser, William G ^a,b   Shankland, Stuart J ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase; Glomerulus; Injury; Kidney; p21; Podocyte; Visceral glomerular epithelial cells

Indexed keywords

CYCLINE; PHOSPHOTRANSFERASE; PROTEIN P21;

ALLERGIC GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GLOMERULUS; GROWTH INHIBITION; GROWTH REGULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033033630     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00504.x     Document Type: Article

References (49)

1. 1. Johnson RJ: The glomerular response to injury: Progression or resolution? Kidney Int 45:1769-1782, 1994
2. 2. Kriz W: Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
3. 3. Rennke HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 45:S58-S63, 1994
4. 4. D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241, 1994
5. 5. Pardee AB: G1 events and regulation of cell proliferation. Science 246:603-608, 1989
6. 6. Sherr CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
7. 7. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551-555, 1994
8. 8. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
9. 9. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge J: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993
10. 10. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai L, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N: Inhibition of cyclin dependent kinases by p21. Mol Biol Cell 6:387-400, 1995
11. 11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: p21WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
12. 12. Noda A, Ning Y, Venable SF, Pereira-Smiths OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using expression vectors. Exp Cell Res 211:90-98, 1994
13. 13. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994
14. 14. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59-66, 1994
15. 15. Zhang P, Liegeois NJ, Wong C, Finegold M, Hou H, Thompson JC, Silverman A, Harper JW, Depinho RA, Elledge SJ: Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwitn-Wiedermann syndrome. Nature 387:151-158, 1997
16. 16. Chen IT, Akamatsu M, Smith ML, Lung F, Duba D, Roleer PP, Fornace AJ Jr: Charaterization of p21 Cip1/Waf1 peptide domains required for cyclin E/CDK2 and PCNA interaction. Oncogene 12:595-607, 1996
17. 17. Chen J, Peters R, Saha P, Lee P, Theodoras A, Pagano M, Wagner G, Dutta A: A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acid Res 24:1727-1733, 1996
18. 18. Zhang H, Xiong Y, Beach D: Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906, 1993
19. 19. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-Independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027, 1995
20. 20. Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413, 1997
21. 21. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21-deficiency. Nature 377:552-557, 1995
22. Kip1 safegaurds against inflammatory injury. Nat Med 4:575-580, 1998
23. 23. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Lab Invest 67:486-497, 1992
24. 24. Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG: Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int 50:116-124, 1996
25. 25. Hugo C, Nangaku M, Shankland SJ, Pichler RH, Gordon KL, Amieva MR, Couser WG, Furthmayr H, Johnson RJ: The plasma membrane-actin linking protein, ezrin, is a glomerular epithelial cell marker in glomerulogenesis, in the adult kidney and in glomerular injury. Kidney Int 54:1934-1944, 1998
26. 26. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B: Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 119:1329-1341, 1993
27. 27. Salant DJ, Darby C, Couser WG: Experimental membranous glomerulonephritis in rats. J Clin Invest 66:71-81, 1980
28. 28. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
29. 29. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578, 1994
30. 30. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8:51-60, 1997
31. 31. Nakanishi M, Adami GR, Robetorye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, Smith JR: Exit from Go and entry into the cell cycle of cells expressing p21Sid1 antisense RNA. Proc Natl Acad Sci USA 92:4352-4356, 1995
32. 32. Missero C, Di Cunto F, Kiyokawa H, Koff A, GPD: The absence of p21 (Cip1/WAF1) alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10:3065-3075, 1996
33. 33. Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, El-Deiry WS, Tyner AL: p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 227:171-181, 1996
34. 34. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/ WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451-5455, 1995
35. 35. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD. Science 267:1018-1021, 1995
36. 36. Steinman RA, Hoffman B, Iro A, Guillouf C, Lieberman DA, El-Houseini ME: Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 9:3389-3396, 1994
37. 37. Saxen L: Organogenesis of the Kidney. Cambridge, Cambridge University Press, 1987
38. 38. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21 (Cip1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684, 1995
39. kip1, in developing and mature human kidney. Kidney Int 53:892-896, 1998
40. 40. Kriz W, Hahnel B, Rosener S, Elger M: Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48:1435-1450, 1995
41. 41. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 7:2271-2278, 1996
42. 42. Wiggens RC, Holzman LB, Legault DJ: Glomerular inflammation and crescent formation, in Immunological Renal Diseases, edited by Neilson EG, Couser WG, Philadelphia. Lippincott-Raven, 1997
43. 43. Lan HY, Nikoloc-Paterson DJ, Atkins RC: Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest 67:743-751, 1992
44. 44. Boucher A, Droz D, Adafer E, Noel LH: Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 56:526-533, 1987
45. 45. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
46. 46. Valeri A, Barisoni L, Appel GB, Seigle R, D' Agati V: Idiopathic collapsing focal glomerulosclerosis: A cinicopathologic study. Kidney Int 50:1734-1746, 1996
47. 47. Freemerman AJ, Vrana JA, Tombes RM, Jiang H, Chellapan SP, FISHER PB, SG: Effects of antisense p21 (WAF1/Cip1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60). Leukemia 11:504-513, 1997
48. 48. Wang J, Walsit K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361, 1996
49. 49. Megyesi J, Saftrstein RL, Price PM: Induction of p21 (WAF1/ Cip1/SDI1) in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101:777-782, 1998